drugset / Trial / NCT02959229

Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis

NCT02959229

Phase 4 Completed 180 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

The present study was designed to evaluate the effectiveness of oral lactoferrin in prevention of neonatal sepsis with comparison early (1st day) versus late (48-72 hours) Lactoferrin administration, Secondary aim was to study effect of Lactoferrin administration on serum Ferritin and follow up long term outcome (Bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis.

Timeline

Start
2014-08
Primary completion
2015-12
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactoferrin Protein / enzyme biologic 100 mg Oral

Indications